Tactile Systems Technology, Inc

Tactile Systems Technology is a U.S.-based medical technology company that develops and sells home-based devices for chronic disease management. Its core offerings address lymphedema, chronic venous insufficiency, and airway clearance therapy, with sales concentrated in the United States through a direct-to-patient and provider model.

10,9 %

75,9 %

5,8 %

+12,5 %

4.03

3.69

— Tactile Systems Technology, Inc
%
Lymphedema therapy systems78% Home-use pneumatic compression devices for lymphedema and related venous disease.
Airway clearance therapy22% Vest-based respiratory therapy devices used to help clear mucus in chronic lung conditions.

The company sells primarily to patients in the United States, with reimbursement and access shaped by physicians,...

  • Lymphedema patientsprimary

    Buy Flexitouch Plus, Entre Plus, and Nimbl systems for home treatment of swelling and related symptoms.

  • Chronic venous insufficiency patientssecondary

    Use compression therapy devices to manage venous disease and related edema.

  • Respiratory patientssecondary

    Buy AffloVest systems for airway clearance in chronic respiratory conditions.

  • Healthcare providers and payersprimary

    Influence product adoption through referrals, coverage decisions, and reimbursement pathways.

The business is concentrated in the United States, which is both its main sales market and operating base...

  • •United States is the core sales and operating market
  • •Direct sales force and reimbursement operations are U.S.-based
  • •Minneapolis metropolitan area houses major corporate/manufacturing functions
  • •Trademark registrations extend to Australia, Japan, EU, New Zealand, and UK
  • •Geographic concentration increases dependence on U.S. payer and regulatory rules

The company’s strategy centers on expanding home-based treatment adoption for underserved chronic diseases through...

01
Expand direct commercial reachshort-term

A direct model helps the company control patient education, access, and conversion.

02
Strengthen reimbursement and payer accessshort-term

Coverage criteria and billing privileges are central to device adoption and revenue realization.

03
Grow the product portfoliomedium-term

New devices broaden the addressable market and reduce reliance on a single product line.

The company depends heavily on Medicare coverage, payer criteria, and durable medical equipment accreditation, so...

high

Medicare coverage and reimbursement changes

A large share of patients rely on Medicare, so coverage criteria directly affect utilization and collections.

Scope
U.S. home-therapy revenue
Materiality
high
high

Competitive pressure in pneumatic compression and airway clearance

Rivals with broader resources or distribution can pressure pricing, share, and customer acquisition.

Scope
Lymphedema and respiratory device markets
Materiality
high
high

Accreditation and licensing compliance

The direct-to-patient model depends on maintaining DME certification and related approvals.

Scope
U.S. operating model
Materiality
high
medium

Cybersecurity and IT disruption

Patient, billing, and operational systems are exposed to intrusion, outage, or data breach risk.

Scope
Commercial and reimbursement systems
Materiality
medium
medium

Product performance and recall risk

Device defects can affect patient safety, trigger field actions, and damage reputation.

Scope
All device lines
Materiality
medium
Revenue recognition and collectability estimates
Can change reported revenue if payer or patient collections differ from estimates
Seasonality
Affects revenue and expense comparability across periods
Contingent consideration / earn-out fair value
Can create non-cash gains or losses in the income statement

TACTILE SYSTEMS TECHNOLOGY INC

TCMD · Surgical & Medical Instruments & Apparatus

Epiroc B

EPI-A.ST · Industrials

Billerud

BILL.ST · Basic Materials

New Wave

NEWA-B.ST · Consumer Discretionary

Apotea

APOTEA.ST · Consumer Staples

Knowit

KNOW.ST · Technology

: 29.4.2026